Detailed biopsy pathologic features as predictive factors for initial reclassification in prostate cancer patients eligible for active surveillance.

MLA

Ploussard, Guillaume, et al. “Detailed Biopsy Pathologic Features as Predictive Factors for Initial Reclassification in Prostate Cancer Patients Eligible for Active Surveillance.” Urologic Oncology, vol. 31, no. 7, Oct. 2013, pp. 1060–66. EBSCOhost, https://doi.org/10.1016/j.urolonc.2011.12.018.

APA

Ploussard, G., de la Taille, A., Terry, S., Allory, Y., Ouzaïd, I., Vacherot, F., Abbou, C.-C., & Salomon, L. (2013). Detailed biopsy pathologic features as predictive factors for initial reclassification in prostate cancer patients eligible for active surveillance. Urologic Oncology, 31(7), 1060–1066. https://doi.org/10.1016/j.urolonc.2011.12.018

Chicago

Ploussard, Guillaume, Alexandre de la Taille, Stéphane Terry, Yves Allory, Idir Ouzaïd, Francis Vacherot, Claude-Clément Abbou, and Laurent Salomon. 2013. “Detailed Biopsy Pathologic Features as Predictive Factors for Initial Reclassification in Prostate Cancer Patients Eligible for Active Surveillance.” Urologic Oncology 31 (7): 1060–66. doi:10.1016/j.urolonc.2011.12.018.